Vaxcyte Inc (PCVX : NASDAQ)
Common Stock
$62.61
USD
+1.15 (1.87%)
Last updated: 2026-10-29
Follow PCVX
PCVX
Vaxcyte Inc
WealthAwesomePerformance
1 Day
+1.87%
1 Week
-0.38%
1 Month
+10.44%
YTD
+23.56%
Key Statistics
Market Cap
$9.85B
52W High
$90.75
52W Low
$39.87
P/E Ratio
-
50 Day MA
$61.59
200 Day MA
$56.97
Beta
1.23
Dividend Yield
-
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 10/29/2026 | $61.88 | $63.14 | $61.64 | $62.61 | $62.61 | 2,012,499 |
| 10/28/2026 | $59.92 | $63.94 | $59.58 | $61.46 | $61.46 | 2,180,640 |
| 10/27/2026 | $59.92 | $61.30 | $59.43 | $60.67 | $60.67 | 2,587,378 |
| 10/26/2026 | $60.68 | $61.50 | $59.19 | $59.97 | $59.97 | 1,469,408 |
| 10/23/2026 | $62.35 | $62.77 | $60.27 | $60.43 | $60.43 | 2,062,400 |
| 10/22/2026 | $62.96 | $64.58 | $61.56 | $62.85 | $62.85 | 2,771,275 |
| 10/21/2026 | $66.02 | $67.47 | $63.09 | $63.23 | $63.23 | 3,272,134 |
| 10/20/2026 | $63.80 | $67.01 | $63.68 | $66.23 | $66.23 | 1,956,844 |
| 10/19/2026 | $64.14 | $66.02 | $63.38 | $63.68 | $63.68 | 2,549,096 |
| 10/16/2026 | $65.13 | $65.34 | $62.54 | $63.62 | $63.62 | 3,249,900 |
Analyst Price Targets
Based on 11 analysts covering PCVX · as of Oct 14, 2026
Wall Street analysts forecast PCVX stock price to rise 87.4% over the next 12 months.
Consensus
Strong Buy4.73 / 5.00
Avg. Target
US$117.30
+87.4% Upside
Previously US$117.00 on Oct 9, 2026
Current Price
US$62.61
Last close
Analyst Breakdown (11 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on PCVX's historical volatility
30-Day Vol
97.2%
Annualized
90-Day Vol
64.4%
Annualized
Trend (90d)
+47.5%
Annualized drift
90d Mean
US$74.18
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | US$66.25 | US$47.37 – US$92.66 |
| 60 trading days | US$70.10 | US$43.62 – US$112.66 |
| 90 trading days | US$74.18 | US$41.49 – US$132.62 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Vaxcyte Inc
Vaxcyte, Inc., a clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent carrier-sparing investigational pneumococcal conjugate vaccine (PCV) for the prevention of invasive pneumococcal disease (IPD) in infants. The company also develops VAX-31, a 31-valent, carrier-sparing investigational PCV for the prevention of IPD in adults and children; VAX-A1, a novel conjugate vaccine candidate to prevent disease caused by Group A Streptococcus; VAX-PG, a novel protein vaccine candidate targeting the keystone pathogen responsible for periodontitis; VAX-GI, a novel preclinical vaccine candidate for the treatment of dysentery and shigellosis, which is caused by Shigella bacteria; and VAX-XL, a third-generation pneumococcal conjugate vaccine. The company was formerly known as SutroVax, Inc. and changed its name to Vaxcyte, Inc. in May 2020. Vaxcyte, Inc. was incorporated in 2013 and is headquartered in San Carlos, California.
Financials
- Revenue (TTM)
- $0
- EBITDA
- $-1.15B
- Profit Margin
- 0.00%
- ROE (TTM)
- -36.51%
- EPS (Diluted)
- -7.62
- Book Value
- 19.05
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Common Questions About PCVX.US
Market movers
Recent NASDAQ movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| PCLA | PicoCELA Inc. American Depositary Shares | $11.10 | +86.09% |
| GENVR | Gen Digital Inc. Contingent Value Rights | $1.75 | +65.09% |
| NCPL | Netcapital Inc | $1.78 | +61.82% |
| INLF | INLIF LIMITED Ordinary Shares | $0.27 | +47.22% |
| XCH | XCHG Limited American Depositary Share | $3.46 | +41.80% |
| AMPGZ | Amplitech Group, Inc. Series B Right | $0.05 | +40.80% |
| SGLY | Singularity Future Technology Ltd | $0.50 | +40.17% |
| JFIN | Jiayin Group Inc | $1.72 | +37.60% |
PCVX.US news timeline
3 articles covering PCVX.US, most recent first
Latest